Gregory M. Fahy

Dr. Fahy is the Executive Director of 21st Century Medicine, Inc. He manages the strategic focus of the company's highly specialized research projects and is responsible, in cooperation with the Chief Operating Officer, for relationships with other businesses and for the general management of 21st Century Medicine.

Dr. Fahy has a strong history of research management. Before joining 21st Century Medicine, he was the Head of the Tissue Cryopreservation Section of the Transfusion and Cryopreservation Research Program of the U.S. Naval Medical Research Institute in Bethesda, Maryland, and he has served as the Chief Scientist or Chief Scientific Officer of Organ, Inc, LRT, Inc., Longevity Bridge, Inc., and Intervene Immune, Inc. He was the director of organ cryopreservation research at the American National Red Cross' Transplantation Laboratory and Blood Research Laboratory in Maryland for 20 years and has been the Chief Scientific Officer of 21st Century Medicine since 2001, before that serving as the company's Vice President for Cryopreservation Research and as its Director of Research from 1999-2001. Dr. Fahy has been the Vice President of 21st Century Medicine since 1999 and has been a member of its Board of Directors since 1999. He has also served on the Board of Directors of Xytex Research, Inc, and Intervene Immune, Inc. and directed a successful human clinical trial.

As a scientist with the American Red Cross, he was the originator of the first practical method of cryopreservation by vitrification and the inventor of computer based systems to apply this technology to whole organs. While at the Naval Medical Research Institute in Bethesda, Maryland, he spearheaded the original concept of ice blocking agents. Since joining 21st Century Medicine, he invented tonicity-mediated chilling injury control, the qv* system for predicting the toxicity of complex cryoprotectant solutions for organized tissues, and the DFE series of cryoprotectant solutions upon which our flagship solution, M22, is based, and he discovered the nucleation inhibiting properties of what is now our Supercool Z-1000 product and designed and built much of the equipment that our current research is now based on. He has published 94 papers, given well over 100 invited presentations, and holds 39 issued US and international patents.

Respected for his expertise and contributions to the advancement of both fundamental and applied cryobiology, Dr Fahy has been named as a Fellow of the Society for Cryobiology and was recently made the President Elect of the Society.

A native of California, Dr. Fahy earned his B.S. in biology from the University of California at Irvine and his Ph.D. in pharmacology and cryobiology from the Medical College of Georgia in 1977. He also studied neurobiology at the Woods Hole Marine Biological Laboratory in Massachusetts in 1980 and received PI Training for Clinical Investigations in 2015.